SquishyAI Research · Moonshots Report · Updated February 2026

Moonshots
2026

Ten structural forces reshaping civilization — and the investment theses that follow. From the efficiency revolution quietly making intelligence cheap, to the minds and machines converging at the edge of human biology.

PublishedFebruary 2026
Moonshots10 Themes
Horizon2026 – 2035
AuthorSquishyAI Research
Scroll

Ten moonshots that will define
the next decade of investment

Something shifted in January 2026. A Chinese lab released a model trained for $6 million that matched the best American AI. The assumption that intelligence scales with capital was broken overnight.

DeepSeek R1 was not just a technical achievement — it was an economic event. It told the market that the cost of intelligence is collapsing faster than anyone modeled. That the $80 billion AI data center buildouts may be simultaneously necessary and insufficient. And that the country winning the AI race is not simply the one spending the most money.

This updated edition of our Moonshots 2026 report incorporates that shift — and three new themes that we believe are now too important to omit. The Efficiency Revolution earns its own section. The Agentic Economy, where AI agents are replacing software subscriptions with autonomous outcomes, is the most consequential enterprise story of this year. And at the outer edge, the convergence of brain-computer interfaces and quantum computing is beginning to look less like science fiction and more like a 5-year horizon.

We remain at the beginning of our journey at SquishyAI. This report is our honest attempt to map what we believe are the most consequential structural forces in the investment landscape — written for people who think in decades, not quarters.

$6M
DeepSeek R1 training cost vs. ~$600M for comparable US models
40%
Enterprise apps expected to have AI agents by end of 2026 — up from <5%
2027
Commonwealth Fusion's SPARC targets net energy — and AGI consensus estimate
$24B
Real-world assets tokenized on-chain — up 800% in three years
01
AI · Foundation

The Intelligence Threshold

The CEOs of the most powerful AI laboratories are no longer being coy. AGI is being measured in months — and the 2027 consensus is hardening into operational planning, not speculation.

Dario Amodei of Anthropic wrote in late 2025 that AI will "gradually get better than us at almost everything" within two to three years. Sam Altman told President-elect Trump that AGI would arrive "during his administration" — a commitment to a sub-four-year timeline from the CEO of the world's most valuable AI company. Google DeepMind's Demis Hassabis calls it "a handful of years away." The range has narrowed dramatically: 2027 is now the consensus near-term target.

What makes this moment different from prior AI hype cycles is the specificity of the claims and the capital being deployed against them. These are not conference keynote projections — they are timelines being used to justify $80 billion annual capital expenditure programs, government intelligence assessments, and geopolitical policy at the highest levels.

What "AGI" Actually Means for Investment

The working definition that matters for investors is not philosophical — it is economic. AGI, as these labs define it, means a system capable of performing virtually any cognitive task a human can do, including scientific research, software engineering, legal reasoning, and financial analysis. The economic implication is that the marginal cost of intelligence approaches zero. A firm that employs 500 analysts could access the equivalent cognitive output of 50,000 — at a fraction of the cost.

The first sectors to be restructured are those with three characteristics: knowledge work is high-value, outputs are well-documented and verifiable, and the incumbent cost structures are bloated. Drug discovery, software engineering, legal services, financial research, and scientific R&D all qualify. These are not small markets.

Signals to Watch

  • Anthropic is already claiming near-term end-to-end automation of software engineering — watch for the first fully autonomous software product shipped by an AI system with minimal human oversight
  • The knowledge worker displacement will not be uniform — it will hit specific roles (junior analyst, junior associate, junior developer) before senior roles, creating a hollowing of entry-level white-collar employment
  • The winners at the AGI layer will be determined by distribution, not benchmarks — whoever embeds the most capable model into the most enterprise workflows captures platform economics
  • Regulatory responses in the EU, UK, and US are accelerating — watch for AI liability frameworks that reshape which industries can deploy frontier models and under what conditions
AGI Timeline — Lab Consensus
Anthropic (Amodei)
2026–2027
OpenAI (Altman)
Pre-2029
Google DeepMind (Hassabis)
"Handful of years"
Industry consensus target
2027
Capital at Stake
Microsoft AI capex (2025)
$80B
Google AI capex (2025)
$75B
Meta AI capex (2025)
$65B
OpenAI valuation
$157B
SquishyAI View

The AGI race is not winner-takes-all at the model level. It is winner-takes-all at the distribution level. The company that embeds the most capable AI into the most workflows first will dominate for a generation. Watch deployment velocity, not benchmark scores.

Key Risk

Timeline compression carries regulatory risk. Governments that feel blindsided by rapid capability gains may impose emergency restrictions that freeze deployment in key sectors at precisely the wrong moment.

02
AI · Economics · New This Edition

The Efficiency
Revolution

DeepSeek trained a frontier AI model for $6 million. The American equivalent cost roughly 100 times more. This is not a Chinese story — it is a fundamental repricing of what intelligence costs, and it changes every investment thesis built on AI scarcity.

In January 2026, DeepSeek released R1 — a reasoning model that matched OpenAI's o1 across math, coding, and complex reasoning benchmarks. The model was trained in approximately two months for under $6 million. Comparable American models are estimated to have cost $500 million to $1 billion to train. The reaction from Silicon Valley was not dismissal — it was alarm. NVIDIA's stock fell nearly $600 billion in market cap in a single day.

The market's initial interpretation was that cheaper AI means less demand for expensive chips and data centers. That interpretation is almost certainly wrong. When intelligence gets cheaper, usage explodes. The history of computing shows this pattern without exception: cheaper transistors didn't reduce demand for chips — they created the PC, the smartphone, and the cloud. Cheaper intelligence will create entire new categories of AI application that were previously uneconomical.

What the Efficiency Curve Actually Means

The DeepSeek result suggests that AI capability is not a simple function of compute expenditure — it is increasingly a function of algorithmic innovation, training efficiency, and data quality. This shifts competitive advantage from raw capital (who can spend the most on compute) toward intellectual capital (who has the best researchers and the smartest training approaches).

"The age of AI as a capital-intensity story is not over. But it is being joined by an AI efficiency story — and the two will coexist in ways that create both new winners and new losers."

For infrastructure investors, the efficiency revolution is a complication but not a negation. Even if training costs fall 10x, inference costs — running models at scale for billions of users — will remain enormous. The demand for compute doesn't decrease as models become cheaper; it increases as deployment widens to use cases previously priced out of the market.

The Open Source Acceleration

DeepSeek's open-source release of R1 is as significant as its efficiency. By releasing the weights publicly, DeepSeek has given every startup, researcher, and government in the world access to a frontier reasoning model they can run, fine-tune, and deploy without paying API fees. This accelerates the entire ecosystem — and directly threatens the revenue models of closed-model providers like OpenAI and Anthropic.

  • Companies that built businesses on top of expensive proprietary AI APIs now have access to comparable open-source models — watch for margin expansion in AI-native software businesses
  • The efficiency curve favors startups: a well-capitalized seed-stage company can now run frontier-class AI experiments that required a hyperscaler's budget 18 months ago
  • Nations previously priced out of frontier AI development now have a path — the geopolitical implications of democratized AI capability are profound and underappreciated
  • NVIDIA's structural advantage shifts from training to inference optimization — watch their software moat (CUDA) more than their hardware spec sheets
The DeepSeek Moment
DeepSeek R1 training cost
~$6M
Comparable US model cost
~$500M–$1B
Cost ratio
~100x cheaper
NVDA 1-day market cap loss
−$593B
Benchmark Performance
DeepSeek R1 vs. OpenAI o1
Comparable
MMLU score
90.8%
DeepSeek API price vs. o1
140x cheaper
License
Open source
SquishyAI View

The Jevons Paradox applies to intelligence: as the cost of running an AI drops by 100x, the number of things it's economical to use AI for expands by far more than 100x. Cheaper models don't reduce AI infrastructure demand — they explode the addressable market for AI applications.

Key Risk

Open-source frontier models create security risks — powerful reasoning capabilities in the hands of malicious actors, with no access controls. Expect regulatory pressure on open-weight releases from governments within 18 months.

03
Infrastructure · Energy · Compute

AI Infrastructure:
The New Arms Race

Even if model training gets cheaper, running AI for billions of users is an insatiable physical problem. Power, cooling, connectivity, and real estate are the constraints that capital cannot simply outspend its way through.

The DeepSeek efficiency revolution did not reduce AI infrastructure demand — it reframed it. Training costs may fall, but inference costs — running models for billions of daily users — remain enormous and are growing. Goldman Sachs projects a 165% increase in AI-driven electricity demand by 2030. The world's power grids were not built for this, and $720 billion in grid infrastructure investment is needed to support it.

The hyperscalers are not pausing. Microsoft committed $80 billion in AI capex in 2025. Google committed $75 billion. Meta committed $65 billion. These are not speculative bets — they are infrastructure obligations already under construction. By 2029, cumulative data center capital expenditure globally is projected to exceed $1.1 trillion.

The Nuclear Pivot

The energy constraint is driving an unexpected renaissance in nuclear power. Microsoft signed a 20-year power purchase agreement with Constellation Energy to restart Three Mile Island's nuclear plant — 835 megawatts of clean, reliable baseload power for Microsoft's AI data centers in the mid-Atlantic region. Google has committed to purchasing output from Kairos Power's small modular reactor fleet — up to 500 megawatts across six to seven reactors targeting deployment from 2030 to 2035. The big tech sector has collectively signed contracts for over 10 gigawatts of potential nuclear capacity in the past year alone.

More consequentially, Commonwealth Fusion Systems is building SPARC — a compact fusion reactor targeting net energy output in 2027. In January 2026, the first of 18 toroidal field magnets was completed and installed, and the company unveiled an AI digital twin built with NVIDIA and Siemens at CES 2026. If SPARC achieves Q>1 in 2027, it will be the most important energy milestone of the century.

The Physical Bottlenecks

The binding constraints on AI infrastructure are not financial — they are physical. High-voltage transformers have a 2–3 year manufacturing backlog. Skilled electrical engineers are scarce. Water for cooling is becoming a political flashpoint between tech companies and municipalities. Land near cheap, reliable power commands extraordinary premiums. These physical constraints create durable competitive moats for the companies solving them.

  • Power generation, transmission, and storage companies are AI infrastructure plays — the market is beginning to price this in, but the full repricing is years away
  • Cooling technology (liquid cooling, immersion cooling) is a high-growth industrial sector driven entirely by AI compute density increases
  • Water infrastructure near major data center corridors — Northern Virginia, Phoenix, Dallas — is under genuine stress and becoming a regulatory and cost variable
  • Nuclear engineering talent is now one of the most strategically scarce professional categories in the developed world
AI Power Demand
Demand increase by 2030
+165%
Required grid investment
$720B
Data center energy (2024)
460 TWh
Data center energy (2030 proj.)
1,000+ TWh
Nuclear Pipeline
Big tech nuclear contracts signed
10+ GW
Three Mile Island restart
835 MW / 2028
CFS SPARC net energy target
2027
SMR commercial deployment
Early 2030s
SquishyAI View

The infrastructure story survives the efficiency revolution intact. Cheaper models mean more applications, which means more inference, which means more power and compute. The bottleneck shifts from training to inference at scale — but the physical infrastructure requirement only grows.

04
AI Agents · Enterprise · New This Edition

The Agentic
Economy

AI agents — systems that perceive, plan, and act autonomously across digital environments — are moving from demos to enterprise deployments at a speed that is restructuring the SaaS business model and the nature of white-collar work simultaneously.

Gartner predicts that 40% of enterprise applications will feature task-specific AI agents by the end of 2026 — up from less than 5% in 2025. IDC projects that AI copilots will be embedded in nearly 80% of enterprise workplace applications by the same date. These are not incremental product improvements — they represent a fundamental shift in what software is for. SaaS companies are no longer selling licenses to tools. They are selling autonomous outcomes.

The market reflects this. The AI agents market reached $7.8 billion in 2025 and is projected to cross $10.9 billion in 2026 — a 43% year-on-year growth rate. By 2030, the market is projected to exceed $50 billion. But these numbers almost certainly undercount the true economic impact, because they measure software revenue, not the labor value being displaced.

What Agents Are Actually Doing Today

The enterprise agent deployments that are generating real business value in early 2026 are less dramatic than the demos — and more consequential. Salesforce's AgentForce is autonomously handling customer service inquiries, lead qualification, and appointment booking. Microsoft Copilot agents are drafting contracts, summarizing earnings calls, and managing project workflows. Legal AI agents are performing document review that previously required junior associates billing at $400 per hour.

The pattern across all early deployments: agents are most effective when operating within well-defined knowledge domains with clear success metrics. The more documented and structured the work, the more replaceable it is by an agent. This makes professional services — legal, financial, consulting, accounting — the highest-value near-term disruption targets.

The Platform Opportunity

The most valuable position in the agentic economy is not building individual agents — it is building the orchestration layer that coordinates multiple agents working in parallel. Just as iOS created more value than any individual iPhone app, the company that builds the dominant enterprise agent platform will capture platform economics. This is the strategic battleground where Microsoft, Salesforce, ServiceNow, and a generation of well-funded startups are competing right now.

"We are not automating tasks. We are automating roles. The unit of AI value creation is shifting from the query to the workflow — and then to the job."
  • 3 in 4 companies surveyed have already invested in AI agents — adoption velocity is faster than any prior enterprise software wave including cloud migration
  • The "outcome-based pricing" model — where software vendors charge per task completed rather than per seat — is gaining traction and will compress legacy SaaS multiples
  • Junior professional roles are the near-term displacement target; watch law firm associate headcount, consulting analyst hiring, and financial services junior staff levels as leading indicators
  • Agent security and trust is the unsolved problem — autonomous agents with access to sensitive systems create entirely new attack surfaces that the security industry is only beginning to address
Agentic Economy Scale
AI agents market (2025)
$7.8B
AI agents market (2026 proj.)
$10.9B
AI agents market (2030 proj.)
$50B+
CAGR
43–45%
Enterprise Adoption (2026)
Apps with AI agents (Gartner)
40% by yr-end
Apps with agents in 2025
<5%
Companies investing in agents
75%
Microsoft Copilot users
50M+
SquishyAI View

The agentic transition is not a feature update — it is a business model disruption. The SaaS companies that survive will be those that pivot to outcome-based pricing before their competitors do. The ones that don't will face the same fate as on-premise software vendors faced when cloud arrived.

Key Risk

Agent reliability is not solved. Autonomous agents that make consequential errors in enterprise settings create significant liability exposure. Expect high-profile failures in 2026 that slow adoption in regulated industries — finance, healthcare, legal.

05
Robotics · Labor · Manufacturing

The Humanoid
Labor Revolution

Tesla began mass production of Optimus Gen 3 on January 21, 2026. The humanoid robot is no longer a prototype — it is a factory product with a $20,000–$30,000 target price and a roadmap to millions of units per year.

The humanoid robot transition crossed a meaningful threshold in early 2026. Tesla's Optimus Gen 3 entered mass production at the Fremont factory on January 21st — with over 1,000 units deployed across Tesla's own manufacturing facilities. The robots are still in a learning and data collection phase, not yet performing economically valuable work independently, but the infrastructure for scale is being built in real-time. Tesla's stated target is to ramp Optimus V3 to 1 million units per year by late 2026, with a dedicated Optimus factory at Gigafactory Texas targeting 10 million units annually by 2027.

Figure AI, meanwhile, closed a Series C at a $39 billion post-money valuation and released Figure 03 — optimized for industrial workflows and complex manipulation. Its Helix AI system is designed specifically for unpredictable real-world environments, which is the core technical challenge separating robots that work in structured factories from those that can work in homes and service environments.

The Labor Economics Are Clear

At Tesla's target price of $20,000–$30,000, a humanoid robot becomes cost-competitive with a human worker earning $40,000–$50,000 annually within a two-year payback window — before accounting for the robot's 22-hour operating day, zero benefits cost, and software-upgradeable capabilities. The economic case is not speculative; it is arithmetic. The question is execution speed, not economic logic.

The deployment wave will follow a clear sequence: first, controlled environments with well-defined tasks (automotive assembly, logistics, electronics manufacturing); then, semi-structured environments (warehouses, retail stockrooms); finally, fully unstructured environments (care, hospitality, construction). Each stage requires significant advances in dexterity, perception, and task generalization — but the trajectory is clear.

The Component Supply Chain

The humanoid buildout creates structural demand for precision actuators, tactile force sensors, edge AI inference chips, high-energy-density battery cells, and physics simulation software. These are not commoditized components — they are scarce, technically demanding, and produced by a small number of specialized suppliers. The companies solving component constraints will earn outsized margins in an otherwise competitive hardware landscape.

  • Tesla's vertical integration advantage is significant — they manufacture their own actuators, chips, and batteries, giving them cost and supply chain control that pure-play robot companies cannot match
  • The "iOS for robots" thesis: the company building a unified cross-hardware training and deployment platform captures more value than any single robot manufacturer
  • Watch Unitree (China) as the low-cost disruptor — their humanoid platforms are reaching $16,000 price points, establishing a cost floor that will pressure Western manufacturers
  • Labor market politics are arriving faster than the robots themselves — proactive engagement with policy and unions will separate long-term deployment winners from those facing regulatory blockades
Humanoid Robot 2026
Tesla Optimus Gen 3 production start
Jan 21, 2026
Optimus units deployed (Tesla)
1,000+
Target price (full scale)
$20–30K
Figure AI valuation (Series C)
$39B
Market Trajectory
Market size by 2035
$38B
CAGR (2025–2035)
39%
Unitree low-cost floor
~$16K
Tesla 2027 capacity target
10M units/yr
SquishyAI View

1,000 Optimus robots in a Tesla factory is not a pilot program — it is the beginning of a production learning curve. Every robot deployed generates training data that makes the next generation more capable. Tesla's advantage compounds with scale in a way competitors cannot easily replicate.

06
Biotech · AI · Longevity

Biology Becomes
Programmable

The first AI-designed drug candidate has received an official nonproprietary name from the US Adopted Names Council. 200 more AI-enabled drugs are in clinical pipelines. The biology-as-software thesis is producing real clinical results.

In March 2025, the US Adopted Names Council assigned the official nonproprietary name "Rentosertib" to Insilico Medicine's ISM001-055 — a TRAF2/Nck protein kinase inhibitor for idiopathic pulmonary fibrosis that was discovered entirely by AI and taken from target identification to Phase I in 18 months, versus the traditional five-year timeline. Its Phase IIa results were positive. This is not a proof of concept — it is a clinical milestone that validates the entire AI drug discovery thesis at the regulatory level.

The pipeline behind it is substantial: over 200 AI-enabled drug candidates are in clinical development globally as of early 2026. AI-discovered drugs are showing Phase I success rates of 80–90%, compared to 40–65% for traditionally discovered drugs. The FDA issued its first formal guidance on AI use in drug development in January 2025, creating the regulatory framework that will govern the first approvals — expected in 2026–2027.

The Longevity Capital Wave

Separately from AI drug discovery, a structural shift in capital allocation toward longevity science is underway. Altos Labs, backed by $3 billion including significant capital from Jeff Bezos, is pursuing cellular reprogramming — the process of reverting aged cells to a younger epigenetic state. Calico (Google-backed) and Unity Biotechnology are advancing senolytic therapies that clear senescent cells linked to aging-related disease. These programs are 5–10 years from clinical translation but represent a bet on the single largest addressable market in human history: the biology of aging itself.

The mRNA Platform Continues to Expand

COVID-19 validated mRNA as a programmable therapeutic platform that can be updated like software. Moderna and BioNTech are advancing mRNA oncology programs — personalized cancer vaccines that generate a patient-specific immune response against their tumor's unique mutation profile. Early results in melanoma and lung cancer are generating serious clinical interest. If mRNA personalized oncology works, it fundamentally changes cancer treatment economics.

  • Rentosertib's naming is a legal and regulatory milestone — it demonstrates that an AI-discovered drug can navigate the full FDA pathway, removing the last significant uncertainty about the regulatory viability of AI pharma
  • The 80–90% Phase I success rate for AI drugs (vs. 40–65% for traditional) suggests AI is genuinely improving the biology, not just the paperwork — this is the strongest signal the thesis is working
  • Longevity science is early but political: aging populations in Japan, South Korea, Europe, and the US are creating policy pressure to accelerate anti-aging research — regulatory pathways may be more permissive than historical precedent suggests
  • Wearable biosensors + AI clinical decision support = preventive medicine at scale. The shift from treating disease to predicting it is a multi-trillion dollar restructuring of global healthcare spend
AI Drug Discovery
First AI drug naming (FDA)
Rentosertib
Time: target ID → Phase I (AI)
18 months
Traditional equivalent
5+ years
AI drugs in clinical trials
200+
Longevity Capital
Altos Labs total raise
$3B
AI Phase I success rate
80–90%
Traditional Phase I success
40–65%
First AI drug approval (est.)
2026–2027
SquishyAI View

The most asymmetric bet in biotech is not a single drug — it is a discovery platform. Insilico's model is not just finding one drug; it is a factory. The companies that own AI drug discovery platforms will generate pipelines that no traditional pharma company can match on speed or cost.

07
Geopolitics · Trade · Sovereignty

The Geopolitics
of Technology

DeepSeek proved that export controls on advanced chips did not stop China from reaching frontier AI. This changes the geopolitical calculus — and every investment thesis that assumed American AI supremacy was guaranteed by hardware access control.

The US semiconductor export control regime was built on a single assumption: deny China access to the most advanced chips, and you deny China access to frontier AI. DeepSeek R1 is a direct empirical refutation of that assumption. Using restricted hardware — NVIDIA H800s, not H100s — DeepSeek trained a frontier reasoning model for $6 million. The policy implication is profound: hardware denial alone is an insufficient strategy for maintaining AI supremacy.

This does not mean export controls are useless. They slow China's progress — they do not stop it. But the margin of American advantage, which policy architects assumed was measured in years, may be measured in months. The US government's response — accelerating domestic AI infrastructure investment, expanding the CHIPS Act's scope, and tightening controls on chip manufacturing equipment (not just chips) — reflects an updated understanding of where the real leverage lies.

The Friendshoring Reality

Regardless of AI supremacy debates, the structural decoupling of global technology supply chains is permanent and irreversible on any investable horizon. TSMC is building advanced fabs in Arizona (4nm production from 2026), Germany (Dresden), and Japan (Kumamoto). Samsung and Intel are building fabs in Texas and Ohio respectively. The CHIPS Act has committed $52.7 billion to US semiconductor manufacturing — with the full multiplier effect of private co-investment approaching $400 billion.

This is not just an American story. The EU Chips Act, Japan's semiconductor sovereignty program, India's semiconductor mission, and South Korea's domestic chip investment are all manifestations of the same geopolitical imperative: technological self-sufficiency is the new energy security.

AI Sovereignty as Strategic Asset

The DeepSeek efficiency breakthrough has paradoxically accelerated AI nationalism. If frontier AI can be achieved at a fraction of the previously assumed cost, then middle powers — Saudi Arabia, UAE, India, South Korea, France — now have credible paths to national AI sovereignty that were previously unaffordable. This is creating enormous demand for sovereign AI infrastructure: on-premise data centers, national LLM programs, and AI systems trained on domestic data under domestic control.

  • The export control regime will tighten in response to DeepSeek — expect restrictions on AI training algorithms and data, not just hardware, in coming policy iterations
  • Defense tech is the fastest-growing segment of the US technology sector — autonomous drones, AI-enabled intelligence, and software-defined warfare are attracting capital at unprecedented rates
  • The middle powers (India, UAE, Saudi Arabia) are positioning as AI swing players — building sovereign models while maintaining economic relationships with both the US and China
  • Cybersecurity is a structural growth market for the next decade — the attack surface created by AI-enabled offensive capabilities vastly exceeds the defensive infrastructure currently in place
Geopolitical Tech Data
US CHIPS Act commitment
$52.7B
Private co-investment multiplier
~$400B
TSMC Arizona (2026)
4nm live
China domestic semi investment
$150B+
The DeepSeek Policy Shock
Chips used (restricted class)
H800s (not H100s)
Policy assumption invalidated
Hardware = moat
New policy focus
Algorithm + data
SquishyAI View

DeepSeek doesn't weaken the geopolitical AI competition — it intensifies it. The US response will be to accelerate domestic AI investment, tighten controls further, and push allies harder on alignment. Defense and sovereignty infrastructure will be among the fastest-growing segments of government-adjacent tech investment through 2030.

08
Energy · Climate · Fusion

Energy Abundance
Through Clean Tech

Solar and battery deflation are reshaping energy economics globally. Nuclear is staging an unexpected comeback driven by AI demand. And Commonwealth Fusion Systems is targeting net energy from fusion in 2027 — a milestone that would dwarf every other energy story of this century.

The deflationary curves in solar and battery storage are among the most reliable trends in the investment landscape. Solar panel costs have fallen 90% in the last decade. Battery storage costs have fallen more than 80%. These are not policy-dependent improvements — they are technology learning curves that continue regardless of political winds. The IEA forecasts peak fossil fuel demand before 2030. The world added a record 500 gigawatts of renewable energy in 2023 and growth is accelerating.

Cheap clean energy is not primarily a climate story — it is an industrial competitiveness story. The country or company that secures access to abundant, cheap, reliable electricity in the next five years gains structural cost advantages that compound for decades. Aluminum smelting, steel production, semiconductor fabrication, green hydrogen production, and AI compute are all intensely energy-sensitive. The geography of energy abundance is becoming the geography of industrial advantage.

The Fusion Inflection

Commonwealth Fusion Systems' SPARC project deserves its own attention. In January 2026, the first of 18 toroidal field superconducting magnets was completed and installed at the SPARC facility in Massachusetts. CFS unveiled an AI digital twin of SPARC built in collaboration with NVIDIA and Siemens at CES 2026 — used to optimize plasma performance before first plasma. The target: net energy output (Q>1) in 2027. If achieved, this is not just a physics milestone — it is the beginning of the end of the fossil fuel era on a 20–30 year horizon.

"Fusion has always been 30 years away. SPARC's magnet milestone suggests it may now be 12 months away — and the difference between 30 years and 12 months is not just time. It is everything."

The Grid Transformation Opportunity

Even without fusion, the grid transformation underway is one of the largest infrastructure investment cycles in history. Utilities must replace aging transmission infrastructure, add massive storage capacity, and integrate intermittent renewables at unprecedented scale. This creates structural demand for power electronics, grid software, long-duration storage technologies, and high-voltage transmission equipment that will persist for decades.

  • The CFS SPARC result in 2027 (positive or negative) will be the most important single data point for energy investors this decade — position accordingly
  • Green hydrogen economics improve with every cent solar and electrolysis costs fall — watch the levelized cost of green hydrogen vs. natural gas as the inflection indicator
  • Countries with abundant renewables and grid stability (Chile, Morocco, Australia, Norway) are becoming attractive destinations for energy-intensive AI and manufacturing investment that is reshoring away from unstable grid regions
  • Long-duration energy storage is the missing piece in a fully renewable grid — iron-air, flow, and compressed air technologies are approaching commercial viability for multi-day storage
Clean Energy Metrics
Solar cost decline (10yr)
−90%
Battery cost decline (10yr)
−80%
New renewables added (2023)
500GW
Peak fossil fuel demand (IEA)
Pre-2030
Fusion: SPARC Timeline
First magnet installed
Jan 2026
Net energy (Q>1) target
2027
AI digital twin partner
NVIDIA + Siemens
Total magnets to install
18
SquishyAI View

Fusion is no longer speculative. SPARC's milestones are happening on schedule, with credible engineering backing. A 2027 net energy result would trigger the largest reallocation of energy infrastructure capital in history. Even a partial success resets expectations for what long-duration clean baseload looks like.

09
Finance · Tokenization · DeFi

The New Financial
Architecture

Real-world asset tokenization has grown 800% in three years and crossed $24 billion. BlackRock's tokenized fund crossed $1 billion AUM. The financial system is being rebuilt on programmable rails — and it is happening faster than most financial institutions have acknowledged.

The tokenization of real-world assets — representing physical and financial assets as programmable tokens on distributed ledgers — has moved decisively from pilot to production. The market reached $24 billion in 2025, up 308% in three years. Total value locked across tokenization protocols reached $65 billion in 2025, an 800% jump from 2023. BlackRock's BUIDL fund (tokenized US Treasury bonds) crossed $1 billion AUM in March 2025 and was subsequently approved for use as off-exchange collateral — a landmark that brings tokenized assets into the mainstream of institutional finance.

JPMorgan, Citi, Goldman Sachs, and HSBC all have active institutional tokenization programs. Over 200 institutional RWA tokenization projects are underway globally. Citi Token Services has been live since 2024, offering blockchain-based cross-border payments and trade finance to institutional clients. The institutional infrastructure is not being built in anticipation of future demand — it is being built to serve existing demand from clients who want the settlement speed and programmability that tokenized rails provide.

Why the Settlement Advantage is Durable

The core value proposition of tokenization is not philosophical — it is operational. Traditional financial settlement takes two business days (T+2), requires multiple intermediaries, operates only during business hours, and is subject to counterparty and custodial risk at every step. Tokenized settlement is near-instantaneous, 24/7, and programmable. For institutions managing trillions in cross-border transactions, even marginal improvements in settlement efficiency generate billions in freed-up collateral and reduced counterparty exposure annually.

"The financial system being rebuilt is not crypto-native — it is traditional asset classes running on crypto-native infrastructure. The pipes are new. The water is familiar."

The Broader Market Projection

McKinsey projects the tokenized asset market at $2 trillion by 2030. More aggressive forecasts from Citi and Standard Chartered put the figure at $4–16 trillion. The broader asset tokenization market — including tokenized funds, structured products, and digital securities — is projected at $3 trillion in 2026 alone, growing at 44% CAGR to $18.7 trillion by 2031. These are not fringe projections — they are coming from the sell-side research desks of the institutions building the infrastructure.

  • The infrastructure layer — tokenization platforms, digital custodians, compliance middleware, cross-chain settlement — captures more durable value than any individual tokenized asset class
  • Central bank digital currencies are in active pilot in 130+ countries — the eventual CBDC infrastructure will use many of the same technical rails as private tokenization platforms
  • Fractional ownership of previously illiquid assets (private equity, real estate, infrastructure) creates entirely new investor access stories — the democratization of alternative assets is a genuine structural shift
  • DeFi's second act — bringing real-world assets on-chain as collateral and yield sources — is more economically significant than the first act, because it has genuine utility beyond crypto speculation
Tokenization Market
RWA tokenized (excl. stablecoins)
$24B (2025)
3-year growth
+308%
Total value locked (2025)
$65B
3-year TVL growth
+800%
Institutional Adoption
BlackRock BUIDL AUM
$1B+ (Mar 2025)
Active institutional RWA projects
200+
McKinsey 2030 projection
$2T
Broader market 2031 proj.
$18.7T
SquishyAI View

$24 billion in tokenized assets sounds large. It is less than 0.1% of the global financial system. The transition has barely begun. The infrastructure being built today by BlackRock, JPMorgan, and Citi is the foundation for a multi-decade repricing of financial intermediation costs.

10
BCI · Quantum · New This Edition

Minds &
Machines

Neuralink has 12 human patients. Synchron has 50. IBM expects verified quantum advantage in 2026. The boundaries between biological intelligence and silicon intelligence are being probed at the edges — and the results are arriving faster than the mainstream acknowledges.

This moonshot combines two themes that share a common thread: the boundary between human cognition and machine capability is becoming technically addressable. Brain-computer interfaces and quantum computing are both early-stage, both subject to serious technical uncertainty, and both capable of generating non-linear discontinuities in capability — the kind of step-change that creates multi-decade compounding opportunities for correctly positioned investors.

Brain-Computer Interfaces: From Science to Scale

Neuralink has implanted 12 patients as of September 2025, raised a $650 million Series E in June 2025, and is transitioning to high-volume production with increasingly automated surgical procedures. Its UK expansion — the GB-PRIME study at UCLH and Newcastle — demonstrates the regulatory pathway outside the US is opening. A UK patient was controlling a computer within hours of surgery.

Synchron has implanted its Stentrode device in over 50 patients with paralysis, with no serious adverse events reported. Critically, Synchron's integration with Apple Vision Pro and NVIDIA AI in 2025 demonstrated a commercially relevant use case: ALS patients controlling digital and physical environments entirely by thought. This is not a medical device story — it is the beginning of a new human-computer interface story.

The near-term market is clearly medical: motor paralysis, ALS, severe epilepsy, treatment-resistant depression. But the longer-term vision — consumer-grade BCIs that augment cognitive bandwidth for healthy users — is the trillion-dollar bet that is attracting deep-pocketed strategic investors. Elon Musk has said publicly that Neuralink's long-term goal is to give humans a "tertiary layer" of intelligence to complement the limbic and cortical systems. Whether or not that vision materializes on his timeline, the infrastructure being built for medical BCIs is the foundation for it.

Quantum Computing: The 2026 Inflection

IBM's quantum roadmap targets verified quantum advantage — a genuine speedup over classical computers on a real business problem — by end of 2026, using its 120-qubit Nighthawk processor. Google's Willow chip (105 superconducting qubits) demonstrated exponential error reduction as qubit counts increased — crossing the "below threshold" milestone that has been the field's central technical challenge for two decades. Microsoft unveiled Majorana 1 in July 2025, a novel topoconductor-based qubit architecture that, if it delivers on its theoretical promise, could produce the most stable logical qubits in the field.

The quantum computing market crossed $1 billion in revenue for the first time in 2025. The first applications reaching commercial advantage are narrow but real: quantum chemistry simulations for drug discovery and materials science, optimization problems in logistics and finance, and specific cryptography applications. The 2026–2027 window is when the field transitions from "promising" to "proven" in at least one commercial domain.

  • BCIs are a 20-year story for consumer applications but a 5-year story for medical applications — position in the medical trajectory and gain optionality on the consumer transition
  • Quantum advantage in chemistry simulation has direct implications for drug discovery and materials science — the first company to demonstrate quantum-accelerated drug candidates will attract enormous capital
  • The quantum-AI convergence is underway: quantum machine learning, quantum-enhanced optimization, and quantum random number generation are all areas where the two technologies amplify each other
  • Post-quantum cryptography is not optional — every institution that holds sensitive long-term data must assume that quantum computers will eventually be able to break current encryption, and transition timelines are shorter than most security teams believe
Brain-Computer Interfaces
Neuralink patients implanted
12 (Sep 2025)
Neuralink Series E raise
$650M
Synchron patients (Stentrode)
50+
Synchron adverse events
Zero serious
Quantum Computing
Industry revenue (2025)
$1B+ (first time)
IBM verified advantage target
End of 2026
Google Willow qubits
105
IBM Kookaburra qubits
1,386
SquishyAI View

BCIs and quantum computing are the two themes in this report most likely to produce 100x outcomes — and most likely to disappoint on near-term timelines. They belong in a patient, diversified portfolio as asymmetric options on civilizational-scale capability shifts. Size appropriately. Hold long.

Key Risk

Both technologies have a history of overpromising on timelines. IBM has moved quantum advantage targets before. Neuralink's consumer ambitions are years from regulatory approval. These are 10-year bets dressed up in 2-year language — price and position accordingly.

The patient investor
sees what others won't

Every idea in this report will be dismissed by someone as too early, too speculative, or too uncertain. That is the nature of genuine structural change — and it is precisely why disciplined, early-positioned investors earn the returns that others rationalize away afterward.

SquishyAI is at the beginning of its journey. This report is our honest attempt to map the forces that are already in motion — updated as the evidence changes, not as the consensus shifts. We invite you to think alongside us.

Join Our Waitlist → Read Our Insights

Disclaimer: This report is published by SquishyAI for informational and educational purposes only. Nothing contained herein constitutes financial, investment, legal, or tax advice. All data and projections cited are from publicly available third-party sources and are believed to be accurate as of February 2026, but are not guaranteed. Forward-looking statements involve risks and uncertainties. Past performance is not indicative of future results. SquishyAI does not manage public funds and does not solicit investment. Always conduct your own due diligence and consult a qualified financial advisor before making investment decisions.

© 2026 SquishyAI. All rights reserved. squishyai.io